Celestoderm-V cream 0.1% 30gr

Celestoderm-V cream instruction

You can buy Celestoderm-V on this page

See also - Celestoderm-V with garamycin

Composition

The Celestoderm-V cream in an amount of 1 gram contains 1 mg of betamethasone. Additional substances: cetostearyl alcohol, liquid paraffin, sodium hydroxide, white soft paraffin, phosphoric acid, macrogol-cetostearyl ether, sodium dihydrogenphosphate dihydrate, water, chlorocresol.

Form of issue

White homogeneous cream of a soft consistence, with no visible inclusions. 15 or 30 grams of cream in an aluminum tube, 1 tube in a cardboard bundle.

pharmachologic effect

Local glucocorticoid action.

Pharmacodynamics and pharmacokinetics

Has anti-inflammatory and antiallergic effect due to inhibition of the release of inflammatory mediators and cytokines, slowing the metabolism of arachidonic acid, lowering the permeability of arteries and veins, stimulating the synthesis of lipocortins, having anti-edematous effect.
Celestoderm-V actively penetrates the skin and quickly has a curative effect.

Indications for use

Inflammatory skin diseases sensitive to glucocorticosteroid therapy:
    contact and seborrheic dermatitis;
    radiation dermatitis;
    eczema;
    sunny dermatitis;
    neurodermatitis;
    exfoliative dermatitis;
    psoriasis;
    intertriginous dermatitis;
    anogenital itching.

Contraindications

    allergy to the components of the drug;
    pregnancy and lactation;
    age less than 6 months.

Side effects

When using topical glucocorticosteroids, the following adverse reactions were recorded: irritation, dryness and burning of the skin at the site of application, hypertrichosis, folliculitis, hypopigmentation, acne, allergic dermatitis, neutral dermatitis, skin maceration, skin atrophy, secondary infection, sweating and striae.

Instructions for the use of Celestoderm-V (Method and dosage)

Cream Celestoderm-V, instructions for use

The cream is applied only externally. It should be applied to the affected areas with a thin layer up to three times a day, depending on the severity of the disease. To achieve the effect, in most cases it is sufficient to apply twice a day.

Overdose

Signs of an overdose: excessive or prolonged local administration of glucocorticosteroids may cause suppression of the pituitary and adrenal glands, which may cause secondary hypofunction of the adrenal cortex and symptoms of hypercorticism, including Cushing's syndrome.
Overdose therapy: symptomatic treatment. If necessary, monitoring and correction of electrolyte imbalance is recommended. Acute hypercorticism, as a rule, is reversible. In the case of prolonged exposure, slow elimination of glucocorticosteroids is recommended.

Interaction

There is no data on interactions with other drugs.

Storage conditions

Store at temperatures up to 25 ° C. Keep away from children.
Shelf life - 5 years.

special instructions

If the effect of treatment is absent within 14 days, then it is necessary to consult a doctor with the purpose of clarifying the diagnosis.
If, when using the drug, irritation or an allergic reaction is detected, the treatment should be stopped and the patient should be adequately treated.
When developing a secondary bacterial or fungal infection, it is recommended that appropriate medications be prescribed. If this rapid healing effect is not achieved, then the use of glucocorticosteroids should be discontinued until all signs of infection are eliminated.
Any adverse reactions of systemic glucocorticosteroids, including oppression of the adrenal glands, can also be recorded with the use of local glucocorticosteroids, especially in children.
Absorption of local glucocorticosteroids into the systemic circulation is increased with their long-term use, in the treatment of large body surfaces or in the application of occlusive dressings, and in the treatment of children.
Cream and ointment Celestoderm-V is only allowed for external use and is prohibited for use in ophthalmology.
The following adverse reactions were recorded in children receiving the described agent: Cushing's syndrome, suppression of the hypothalamic-pituitary-adrenal system, growth retardation, increased intracranial pressure, and a lag in weight gain. Signs of oppression of the adrenal cortex in children of childhood include: a decrease in the content of cortisol in the blood, the lack of response to activation of adrenocorticotropic hormone. Strengthening of intracranial pressure can be detected by the bulging of the fontanel, edema of the disc of the optic nerve and is accompanied by a headache.

Children

The drug is approved for use in children older than 6 months. Children of childhood are more susceptible to treatment with local glucocorticosteroids than adult patients, due to increased absorption of the drug.

In pregnancy and lactation

Safety of use of the drug in pregnant women is not established, therefore its appointment during pregnancy can be justified only in the presence of strict indications and under the supervision of the attending physician. The described agent should not be given to pregnant women at high dosages or for a long time.
To date, it has not been determined whether local glucocorticosteroids can be excreted in breast milk, so breast-feeding or taking the drug should be stopped, given the need for its use for the mother.

Reviews of Celestoderm-V

Reviews on the cream, as well as reviews on the Celestoderm-V ointment, in most cases highly appreciate the therapeutic effect of the drug, but indicate that it is temporary and for a number of disorders the drug should be used regularly. Adverse events occur inefficiencies infrequently.

The drug Celestoderm-V - hormonal or not?

One of the most frequently asked questions by patients. Yes, this drug is hormonal.